Literature DB >> 17978616

Withdrawal of cardiac medications and devices.

Debra Lynn-McHale Wiegand1, Peggy G Kalowes.   

Abstract

Withdrawal of life-sustaining therapies such as cardiac medications, pacemakers, internal cardioverter defibrillators, and ventricular assist devices occurs in patients with advanced cardiac disease as goals of treatment transition from active to less aggressive. This article defines life-sustaining therapies and describes ethical and legal considerations related to withdrawal of cardiac medications and cardiac devices. Healthcare providers need to anticipate clinical situations in which implantable cardiac devices and medications are no longer desired by patients and/or are no longer medically appropriate. Discussions are important between patients, families, and healthcare providers that focus on each patient's condition, prognosis, advance directives, goals of care, and treatment options. Critical care nurses support each patient and his or her family and work with other members of the healthcare team to achieve a peaceful death.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17978616     DOI: 10.1097/01.AACN.0000298634.45653.81

Source DB:  PubMed          Journal:  AACN Adv Crit Care        ISSN: 1559-7768


  11 in total

1.  Patients' perspectives on end-of-life issues and implantable cardioverter defibrillators.

Authors:  Patricia H Strachan; Sandra L Carroll; Sonya de Laat; Lisa Schwartz; Heather M Arthur
Journal:  J Palliat Care       Date:  2011       Impact factor: 2.250

2.  Prolegomena to any future mereology of the body.

Authors:  Edward Fried
Journal:  Theor Med Bioeth       Date:  2013-10

Review 3.  Palliative care and end-of-life issues in patients treated with left ventricular assist devices as destination therapy.

Authors:  Keith M Swetz; Abigale L Ottenberg; Monica R Freeman; Paul S Mueller
Journal:  Curr Heart Fail Rep       Date:  2011-09

4.  Withdrawing medication: managing medical comorbidities near the end of life.

Authors:  Christopher P O'Brien
Journal:  Can Fam Physician       Date:  2011-03       Impact factor: 3.275

5.  Perspectives on withdrawing pacemaker and implantable cardioverter-defibrillator therapies at end of life: results of a survey of medical and legal professionals and patients.

Authors:  Suraj Kapa; Paul S Mueller; David L Hayes; Samuel J Asirvatham
Journal:  Mayo Clin Proc       Date:  2010-09-15       Impact factor: 7.616

6.  Comprehensive care for mechanical circulatory support: a new frontier for synergy with palliative care.

Authors:  Nathan E Goldstein; Christopher W May; Diane E Meier
Journal:  Circ Heart Fail       Date:  2011-07       Impact factor: 8.790

7.  End-of-life discontinuation of destination therapy with cardiac and ventilatory support medical devices: physician-assisted death or allowing the patient to die?

Authors:  Mohamed Y Rady; Joseph L Verheijde
Journal:  BMC Med Ethics       Date:  2010-09-15       Impact factor: 2.652

8.  Heart failure symptom assessment and management: can caregivers serve as proxy?

Authors:  Christina Quinn; Sandra B Dunbar; Melinda Higgins
Journal:  J Cardiovasc Nurs       Date:  2010 Mar-Apr       Impact factor: 2.083

9.  Decision making in advanced heart failure: a scientific statement from the American Heart Association.

Authors:  Larry A Allen; Lynne W Stevenson; Kathleen L Grady; Nathan E Goldstein; Daniel D Matlock; Robert M Arnold; Nancy R Cook; G Michael Felker; Gary S Francis; Paul J Hauptman; Edward P Havranek; Harlan M Krumholz; Donna Mancini; Barbara Riegel; John A Spertus
Journal:  Circulation       Date:  2012-03-05       Impact factor: 29.690

10.  Ethical challenges with the left ventricular assist device as a destination therapy.

Authors:  Aaron G Rizzieri; Joseph L Verheijde; Mohamed Y Rady; Joan L McGregor
Journal:  Philos Ethics Humanit Med       Date:  2008-08-11       Impact factor: 2.464

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.